These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 8118385

  • 1. Reliability of measurements of total, protein-bound, and unbound estradiol in serum.
    Toniolo P, Koenig KL, Pasternack BS, Banerjee S, Rosenberg C, Shore RE, Strax P, Levitz M.
    Cancer Epidemiol Biomarkers Prev; 1994; 3(1):47-50. PubMed ID: 8118385
    [Abstract] [Full Text] [Related]

  • 2. The relationship between endogenous estrogen, sex hormone-binding globulin, and bone loss in female residents of a rural Japanese community: the Taiji Study.
    Yoshimura N, Kasamatsu T, Sakata K, Hashimoto T, Cooper C.
    J Bone Miner Metab; 2002; 20(5):303-10. PubMed ID: 12203037
    [Abstract] [Full Text] [Related]

  • 3. Assay reproducibility of hormone measurements in postmenopausal women.
    Falk RT, Dorgan JF, Kahle L, Potischman N, Longcope C.
    Cancer Epidemiol Biomarkers Prev; 1997 Jun; 6(6):429-32. PubMed ID: 9184776
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Free estradiol and breast cancer risk in postmenopausal women: comparison of measured and calculated values.
    Endogenous Hormones and Breast Cancer Collaborative Group.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1457-61. PubMed ID: 14693737
    [Abstract] [Full Text] [Related]

  • 7. A prospective study of estradiol and breast cancer in Japanese women.
    Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE.
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):575-9. PubMed ID: 10868691
    [Abstract] [Full Text] [Related]

  • 8. Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal women.
    Zeleniuch-Jacquotte A, Toniolo P, Levitz M, Shore RE, Koenig KL, Banerjee S, Strax P, Pasternack BS.
    Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):857-60. PubMed ID: 8634657
    [Abstract] [Full Text] [Related]

  • 9. Bioavailability of estradiol as a marker for breast cancer risk assessment.
    Jones LA, Ota DM, Jackson GA, Jackson PM, Kemp K, Anderson DE, McCamant SK, Bauman DH.
    Cancer Res; 1987 Oct 01; 47(19):5224-9. PubMed ID: 3621208
    [Abstract] [Full Text] [Related]

  • 10. The effects of a low-fat/high-fiber diet on sex hormone levels and menstrual cycling in premenopausal women: a 12-month randomized trial (the diet and hormone study).
    Gann PH, Chatterton RT, Gapstur SM, Liu K, Garside D, Giovanazzi S, Thedford K, Van Horn L.
    Cancer; 2003 Nov 01; 98(9):1870-9. PubMed ID: 14584069
    [Abstract] [Full Text] [Related]

  • 11. Reliability of serum prolactin measurements in women.
    Koenig KL, Toniolo P, Bruning PF, Bonfrer JM, Shore RE, Pasternack BS.
    Cancer Epidemiol Biomarkers Prev; 1993 Nov 01; 2(5):411-4. PubMed ID: 8220084
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period.
    Hankinson SE, Manson JE, Spiegelman D, Willett WC, Longcope C, Speizer FE.
    Cancer Epidemiol Biomarkers Prev; 1995 Sep 01; 4(6):649-54. PubMed ID: 8547832
    [Abstract] [Full Text] [Related]

  • 14. Distribution of 17 beta-estradiol in the sera of normal British and Japanese women.
    Moore JW, Clark GM, Takatani O, Wakabayashi Y, Hayward JL, Bulbrook RD.
    J Natl Cancer Inst; 1983 Oct 01; 71(4):749-54. PubMed ID: 6578370
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period.
    Missmer SA, Spiegelman D, Bertone-Johnson ER, Barbieri RL, Pollak MN, Hankinson SE.
    Cancer Epidemiol Biomarkers Prev; 2006 May 01; 15(5):972-8. PubMed ID: 16702379
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.